The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)
NCT ID: NCT03581227
Last Updated: 2023-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4679 participants
OBSERVATIONAL
2018-10-12
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)
NCT03583099
Developing a COPD Case Finding Methodology for Primary Care
NCT01880177
Michigan Early Disease Progression Cohort
NCT04968249
Temple Health Chest Initiative (THCI 2.0)
NCT06933758
Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)
NCT00889447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For Aim 1 approximately 5,000 patients will be recruited across 100 participating primary care clinics. Eligible participants will undergo a baseline visit during which the CAPTURE tool and PEF will be obtained, as well as spirometry and other participant characteristics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants without a diagnosis of COPD
Men and women aged 45 to 80, who have not been diagnosed with Chronic Obstructive Pulmonary Disease (COPD)
CAPTURE Tool
CAPTURE Tool: a self administered 5-item questionnaire with peak expiratory flow measurements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAPTURE Tool
CAPTURE Tool: a self administered 5-item questionnaire with peak expiratory flow measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Male or female, aged 45-80 years
Exclusion Criteria
2. Treated respiratory infection (with antibiotics and/or systemic steroids) in the past 30 days of baseline
3. Participants unable to perform spirometry due to any of the following conditions within the past 30 days of baseline
1. Chest surgery
2. Abdominal surgery
3. Eye surgery
4. Heart attack
5. Stroke
45 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Michigan
OTHER
National Jewish Health
OTHER
University of Minnesota
OTHER
Duke University
OTHER
Wake Forest University Health Sciences
OTHER
Oregon Health and Science University
OTHER
High Plains Research Network
NETWORK
L.A. Net Community Health Resource Network
OTHER
COPD Foundation
OTHER
University of Kentucky
OTHER
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernando J Martinez, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
MeiLan Han
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LANet
Los Angeles, California, United States
High Plains Research Network
Aurora, Colorado, United States
COPD Foundation
Miami, Florida, United States
Cook County Health
Chicago, Illinois, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Atrium Healthcare
Charlotte, North Carolina, United States
Duke University
Durham, North Carolina, United States
Oregon Rural Practice-based Research Network (ORPRN)
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Martinez FJ, Yawn BP, Angulo D, Lopez C, Murray S, Mannino D, Anderson S, Dolor R, Elder N, Joo M, Khan I, Knox LM, Meldrum C, Peters E, Spino C, Tapp H, Thomashow B, Zittleman L, Brown R, Make B, Han MK; CAPTURE Study Group. Impact of the CAPTURE Chronic Obstructive Pulmonary Disease Screening Tool in U.S. Primary Care: A Cluster-Randomized Trial. Am J Respir Crit Care Med. 2025 May;211(5):789-802. doi: 10.1164/rccm.202405-0921OC.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1803019032-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.